            Statement Of  From Today s HELP Hearing on Prescription Drug User Fee Act Reauthorization                                                                                                                               Press Release    Statement Of  From Today s HELP Hearing on Prescription Drug User Fee Act Reauthorization March 14  2007  WASHINGTON  United States   D OH  released the following statement at todays Health  Education  Labor and Pensions  HELP  Hearing on Prescription Drug User Fee Act Reauthorization Thank you  Mr  Chairman  And thanks to Dr  Von Eschenbach and our other witnesses  I am particularly pleased that Kim Witczak has joined us this morning to share her personal story  Our discussion today is for and about people like Kim  and we should remember that as we discuss the commercial secrets embedded in human experiments  otherwise known as clinical trials  as we discuss the educational value of Madison Avenue generated drug ads  and as we discuss what some would have us believe are the immutable benefits of ever faster approval times for brand name biologics and the incontrovertible dangers of any viable approval process for follow on biologics This hearing is for and about people like Kim  The goal is to maximize the benefits and minimize the risks of prescription drugs and biologics  and thats the only goal  Patients deserve accurate information on those risks and benefits  It is one of the idiosyncrasies of our health care system that Madison Avenue can weigh in on medical decisions  and that we accept that DTC ads are medically accurate in any real sense of that term Patients deserve access to the results of clinical trials  good and bad  People agree to be part of human experiments  They should at least be able to access the results  Patients deserve a safety monitoring system that detects safety issues that are not clear when drugs are approved  particularly as approval times shrink  And patients deserve access to medicines that are affordable  What good are medicines that arent   I want to express my appreciation to Chairman Kennedy and Ranking Member Enzi for taking a first cut at drug safety legislation  It is a solid first step  and I look forward to working with them to build on that foundation  Senators Dodd and Grassley have also put forward drug safety legislation that merits our serious consideration  I appreciate their efforts  I look forward to the testimony of our witnesses and to taking action this year to save lives  by enhancing access to medicines that are beneficial and safe  Thank you  Mr  Chairman                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         